Human Reproductive Technologies: Products and Global Markets
Description
Human Reproductive Technologies: Products and Global Markets
Report Scope:
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
Infertility market — male and female factors, pharmaceuticals, and future advancements.
IVF.
Assistive reproductive technologies.
Fertility diagnostics.
Contraception — pharmaceuticals and devices.
Sexual dysfunction — pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Includes:
36 data tables and 22 additional tables
An updated review of the global markets for human reproductive products and technologies
Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
A relevant patent analysis
Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.
Companies Mentioned
Actavis, Inc.
Bayer Ag
Bristol-myers Squibb Co.
Church & Dwight Company Inc.
Coopersurgical Inc.
Eli Lilly & Co.
Emd Serono, Inc.
Ferring Pharmaceuticals
Glaxosmithkline Plc
Janssen Pharmaceutical
Merck Inc.
Novartis International Ag
Pfizer Inc.
Princeton Biomeditech Corp.
Quidel Corp.
Teva Pharmaceuticals.
Vivus Inc.
Report Scope:
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
Infertility market — male and female factors, pharmaceuticals, and future advancements.
IVF.
Assistive reproductive technologies.
Fertility diagnostics.
Contraception — pharmaceuticals and devices.
Sexual dysfunction — pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Includes:
36 data tables and 22 additional tables
An updated review of the global markets for human reproductive products and technologies
Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
A relevant patent analysis
Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.
Companies Mentioned
Actavis, Inc.
Bayer Ag
Bristol-myers Squibb Co.
Church & Dwight Company Inc.
Coopersurgical Inc.
Eli Lilly & Co.
Emd Serono, Inc.
Ferring Pharmaceuticals
Glaxosmithkline Plc
Janssen Pharmaceutical
Merck Inc.
Novartis International Ag
Pfizer Inc.
Princeton Biomeditech Corp.
Quidel Corp.
Teva Pharmaceuticals.
Vivus Inc.
Table of Contents
193 Pages
- Chapter 1 Introduction
- Study Goals And Objectives
- Reasons For Doing This Study
- What's New In This Update?
- Scope Of Report
- Methodology
- Information Source
- Geographic Breakdown
- Analyst's Credentials
- Bcc Custom Research
- Related Bcc Research Reports
- Chapter 2 Summary And Highlights
- Introduction
- Chapter 3 Industry Overview
- Structure And Function Of The Reproductive System
- Male
- Female
- Neuroendocrine Regulation
- Menarche
- Menstruation Cycle
- Phases Of Sexual Responses
- Male Sexual Response
- Female Sexual Response
- Neurohormonal Control Of The Female And Male Reproductive System
- Effects Of Aging
- Issues And Trends Of Reproductive Health
- Contraceptive Insurance
- Over-the-counter Birth Control Pills
- Pre-implantation Genetic Diagnosis
- Designer Babies
- New Use For Contraceptives
- Aging And Infertility
- Death By Contraceptive Patch
- Sexual Dysfunction And Cancer
- Infertility And Cancer
- Signaling Pathway For Fertility Treatment
- Marketing Tactics
- Male Birth Control
- Merchandising Targeting Women
- Counterfeit Products
- Surplus Embryos And Fetuses
- Stem Cell And Other Controversial Issues — Selected International Views
- Controversial Disposal Of Embryos
- Demographics
- Chapter 4 Infertility Market
- Introduction And Overview Of Infertility
- Definition Of Infertility
- Etiology Of Infertility
- Evaluation Of Fertility
- Unexplained Infertility
- Multiple Births
- Asia Factor
- Chapter 5 Covid-19 Impact
- Introduction
- Covid-19: Impact On The Medical Devices And Pharma Industries
- Decline/Delay In Elective Procedures
- Covid-19 Impact On Supply Chain
- U.S. Supply Chain: Covid-19 Impact
- European Supply Chain: Covid-19 Impact
- Apac Supply Chain: Covid-19 Impact
- China: Covid-19 Impact
- Covid-19 Impact On Medical Device And Pharmaceutical Product Segments
- Covid-19 Impact On Critical Devices
- Covid-19 Impact On Human Reproductive Technologies And Products Markets
- Chapter 6 Methods Of Treatment
- Fertility Pharmaceuticals
- Introduction And Types
- Market Revenues And Forecast
- Future Advancements In Infertility Products
- Competitive Analysis
- Chapter 7 Assistive Reproductive Technologies
- Introduction
- Types
- Ivf
- Ovulation Induction
- Oocyte Retrieval
- Intracytoplasmic Sperm Injection (Icsi)
- Fertilization
- Embryo Transfer
- Results Of Ivf
- Gift
- Zift
- Wombs For Rent
- Oocyte Donation
- Frozen Embryos
- United States Fertility Clinics
- Market Revenues And Forecast
- Future Trends In Assistive Reproductive Technology
- Competitive Analysis
- Chapter 8 Fertility Diagnostics
- Introduction
- Types
- Urine Studies
- Market Revenues And Forecast
- Competitive Analysis
- Future Advancements In Diagnostic Fertility Treatment
- Total Infertility Market Revenues And Forecast
- Chapter 9 Contraception Market
- Introduction And Overview Of Contraception
- Pharmaceuticals
- Types
- Other Drug Regimens For Contraception
- Market Revenues And Forecast
- Competitive Analysis
- Prescription Devices
- Market Revenues And Forecast
- Competitive Analysis
- Future Advancements In Contraception
- Total Market Revenues And Forecast
- Chapter 10 Sexual Dysfunction Market
- Introduction And Overview
- Types Of Sexual Dysfunction
- Causes Of Sexual Dysfunction
- Demographics Of Sexual Dysfunction
- Pharmaceuticals
- Introduction And Types
- Market Revenues And Forecast
- Competitive Analysis
- Devices
- Market Revenues And Forecast
- Future Advancements In Sexual Dysfunction
- Total Market Revenues And Forecast
- Chapter 11 Patents
- Patent Analysis By Manufacturer
- Patent By Company
- Patents By Application
- Infertility Treatments
- Contraception
- Sexual Dysfunction
- Leading Market Manufacturers
- Chapter 12 Total Market
- Total Global Market For Reproductive Technologies And Products, By Region
- North America
- Europe
- Asia-pacific
- Rest Of The World
- Total Market Size By Category
- Industry Participants By Category
- Total Market Size By Product Type
- Chapter 13 Competitive Landscape
- Competitive Analysis
- Chapter 14 Company Profiles
- Actavis, Inc.
- Bayer Ag
- Bristol-myers Squibb Co.
- Church & Dwight Company Inc.
- Coopersurgical Inc.
- Eli Lilly & Co.
- Emd Serono, Inc.
- Ferring Pharmaceuticals
- Glaxosmithkline Plc
- Janssen Pharmaceutical
- Merck Inc.
- Novartis International Ag
- Pfizer Inc.
- Princeton Biomeditech Corp.
- Quidel Corp.
- Teva Pharmaceuticals.
- Vivus Inc.
- Selected List Of U.S. Fertility Clinics
- List Of Companies
- Chapter 15 Appendix: Acronyms
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
